Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brizard

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Presse Medicale (Paris, France : 1983)|August 3, 1988
[Treatment of chronic myeloid leukemia by recombinant alpha interferon and hydroxyurea]F Guilhot, J Tanzer, A Brizard, et al.
Leukemia & Lymphoma|July 27, 2016
Translocation t(12;13)(p13.3;q12.2) is Not Restricted to Lymphoid Malignancies; Report of a Further Case with HypereosinophiliaJ L Huret, A Brizard, E Benz-Lemoine, et al.
Blood|January 11, 2000
Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantationJ C Chomel, F Brizard, A Veinstein, et al.
American Journal of Hematology|September 1, 1993
Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisisF Morel, V Delwail, A Brizard, et al.
Leukemia|July 17, 1998
Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon alpha therapy?F Brizard, J C Chomel, A Veinstein, et al.
Bone Marrow Transplantation|February 1, 1994
Molecular remission after allogeneic bone marrow transplantation for chronic lymphocytic leukemiaA Sadoun, S Patri, V Delwail, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's diseaseL Macchi, R Sarfati, M Guicheteau, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapyF Guilhot, M Ahmad, F X Mahon, et al.
Annales De Genetique|January 1, 1989
Karyotypes of 33 patients with clonal aberrations in chronic lymphocytic leukaemia. Review of 216 abnormal karyotypes in chronic lymphocytic leukaemiaJ L Huret, H Mossafa, A Brizard, et al.
Genes, Chromosomes & Cancer|July 4, 2001
Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)L Dahéron, A Veinstein, F Brizard, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Presse Medicale (Paris, France : 1983)|August 3, 1988
[Treatment of chronic myeloid leukemia by recombinant alpha interferon and hydroxyurea]F Guilhot, J Tanzer, A Brizard, et al.
Leukemia & Lymphoma|July 27, 2016
Translocation t(12;13)(p13.3;q12.2) is Not Restricted to Lymphoid Malignancies; Report of a Further Case with HypereosinophiliaJ L Huret, A Brizard, E Benz-Lemoine, et al.
Blood|January 11, 2000
Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantationJ C Chomel, F Brizard, A Veinstein, et al.
American Journal of Hematology|September 1, 1993
Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisisF Morel, V Delwail, A Brizard, et al.
Leukemia|July 17, 1998
Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon alpha therapy?F Brizard, J C Chomel, A Veinstein, et al.
Bone Marrow Transplantation|February 1, 1994
Molecular remission after allogeneic bone marrow transplantation for chronic lymphocytic leukemiaA Sadoun, S Patri, V Delwail, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's diseaseL Macchi, R Sarfati, M Guicheteau, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapyF Guilhot, M Ahmad, F X Mahon, et al.
Annales De Genetique|January 1, 1989
Karyotypes of 33 patients with clonal aberrations in chronic lymphocytic leukaemia. Review of 216 abnormal karyotypes in chronic lymphocytic leukaemiaJ L Huret, H Mossafa, A Brizard, et al.
Genes, Chromosomes & Cancer|July 4, 2001
Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)L Dahéron, A Veinstein, F Brizard, et al.
Pageof 9